TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9126665

Group type: EXPERIMENTAL
Intervention: Testosterone-enanthate (200 mg/week intramuscularly)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Testolactone (1 g/day orally)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Testosterone-enanthate (200 mg/week) + Testolactone (1 g/day)
Number of subjects: 14
Study: 8243792

Group type: EXPERIMENTAL
Intervention: 10 mg/day cyclobenzaprine at bedtime
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 30 mg/day cyclobenzaprine in three equal doses daily
Number of subjects: 40
Study: 28870463

Group type: EXPERIMENTAL
Intervention: rMal d 1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: rBet v 1
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 26682629

Group type: EXPERIMENTAL
Intervention: Dancing group
Number of subjects: 32

Group type: COMPARATOR
Intervention: Health-related exercise group
Number of subjects: 32
Study: 25615800

Group type: EXPERIMENTAL
Intervention: Integrated model of care
Number of subjects: 327

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 327
Study: 23993401

Group type: EXPERIMENTAL
Intervention: 4 days SBRT (48 Gy for tumors ≤ 3 cm, 52 Gy for tumors > 3 cm)
Number of subjects: 54

Group type: COMPARATOR
Intervention: 11 days SBRT (48 Gy for tumors ≤ 3 cm, 52 Gy for tumors > 3 cm)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 4 days SBRT
Number of subjects: 54

Group type: COMPARATOR
Intervention: 11 days SBRT
Number of subjects: 54
Study: 20678219

Group type: EXPERIMENTAL
Intervention: Combined primary health-care and community-based exercise intervention for 6 months
Number of subjects: 243

Group type: COMPARATOR
Intervention: Individual written prescription for exercise (Control)
Number of subjects: 243
Study: 18483084

Group type: EXPERIMENTAL
Intervention: Resection of primary tumor (Group A)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 8
Study: 16488235

Group type: EXPERIMENTAL
Intervention: Support Vector Machine (SVM) analysis of shoulder strength data
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: SVM-based score
Number of subjects: 45
Study: 12594697

Group type: EXPERIMENTAL
Intervention: Debulking-radiation
Number of subjects: 476

Group type: COMPARATOR
Intervention: Balloon angioplasty (BA) alone
Number of subjects: 476
Study: 11081987

Group type: EXPERIMENTAL
Intervention: Standardized extract SHR/5 of Rhodiola rosea (RRE)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 9225617

Group type: EXPERIMENTAL
Intervention: Sequence trials with implicit instructions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sequence trials with explicit instructions
Number of subjects: 0

Group type: COMPARATOR
Intervention: All random trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Serial reaction time task performance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Complex structural characteristics sequence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recognition memory measures
Number of subjects: 0
Study: 8234437

Group type: EXPERIMENTAL
Intervention: Agiolax
Number of subjects: 77

Group type: COMPARATOR
Intervention: lactulose
Number of subjects: 77
Study: 2418400

Group type: EXPERIMENTAL
Intervention: 5‐fluorouracil (B‐CMF) chemotherapy prior to and two courses after standard therapy
Number of subjects: 83

Group type: COMPARATOR
Intervention: Standard therapy (preoperative irradiation followed by radical surgery)
Number of subjects: 83
Study: 31380764

Group type: EXPERIMENTAL
Intervention: Exercise-enabling methods (MOVit)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional joystick control
Number of subjects: 24
Study: 29183782

Group type: EXPERIMENTAL
Intervention: dolutegravir/abacavir/lamivudine
Number of subjects: 833

Group type: COMPARATOR
Intervention: efavirenz (EFV)/tenofovir (TDF)/emtricitabine (FTC)
Number of subjects: 833
Study: 27310254

Group type: EXPERIMENTAL
Intervention: 450 mg daily valganciclovir (group 1)
Number of subjects: 196

Group type: COMPARATOR
Intervention: 900 mg daily valganciclovir (group 2)
Number of subjects: 196
Study: 24297654

Group type: EXPERIMENTAL
Intervention: Circumferential excisional hemorrhoidectomy (CEH)
Number of subjects: 688

Group type: COMPARATOR
Intervention: Ferguson hemorrhoidectomy (FH)
Number of subjects: 688
Study: 22594981

Group type: EXPERIMENTAL
Intervention: Topical photodynamic therapy using methylene blue and Hypericum perforatum extract
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional approaches (not specified)
Number of subjects: 0
Study: 20718337

Group type: EXPERIMENTAL
Intervention: Cutaneous Mechanical Pressure (CMP) applied to the ipsilateral lateral and medial plantar surface at 50% of leg and foot weight.
Number of subjects: 16
Study: 19005632

Group type: EXPERIMENTAL
Intervention: Hearing-aid fitting according to two different procedures (optimizing speech intelligibility scores and strictly implemented fitting formula)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hearing-aid fitting according to either procedure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participants with greater hearing loss
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: First-time hearing aid users
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bilateral hearing-aid fitting
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hearing-aid fitting
Number of subjects: 0
Study: 15832335

Group type: EXPERIMENTAL
Intervention: High exposure condition (0.63 W/kg 1 g averaged SAR)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Low exposure condition (0.063 W/kg 1 g averaged SAR)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Sham exposure (at least 50 dB below low exposure)
Number of subjects: 58
Study: 12887472

Group type: EXPERIMENTAL
Intervention: Triptorelin 3.75 mg
Number of subjects: 284

Group type: COMPARATOR
Intervention: Leuprolide 7.5 mg
Number of subjects: 284
Study: 10475316

Group type: EXPERIMENTAL
Intervention: 0.75% ropivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: 1:1 mixture of 2% plain lidocaine and 0.5% plain bupivacaine
Number of subjects: 60
Study: 8941467

Group type: EXPERIMENTAL
Intervention: Intensive therapy (HbA1c target of 4.0-6.1%)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Standard therapy (general medical care, one shot of insulin per day)
Number of subjects: 153
Study: 1750748

Group type: EXPERIMENTAL
Intervention: Silver nitrate eyedrops
Number of subjects: 900

Group type: COMPARATOR
Intervention: Oxytetracycline hydrochloride eyedrops
Number of subjects: 900
Study: 7201905

Group type: EXPERIMENTAL
Intervention: Cisplatin (60 mg/m2 IV) administered in the morning (6:00 A.M.)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Cisplatin (60 mg/m2 IV) administered in the evening (6:00 P.M.)
Number of subjects: 11
Study: 30635477

Group type: EXPERIMENTAL
Intervention: Rituximab induction followed by glatiramer acetate (GA) monotherapy
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo induction followed by glatiramer acetate (GA) monotherapy
Number of subjects: 55
Study: 28835387

Group type: EXPERIMENTAL
Intervention: Vitamin D and leucine-enriched whey protein medical nutrition drink (21 g leucine, 9 g carbohydrates, 3 g fat, 800 IU vitamin D3)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Vitamin D and leucine-enriched whey protein medical nutrition drink
Number of subjects: 24

Group type: COMPARATOR
Intervention: Noncaloric placebo
Number of subjects: 24
Study: 26035650

Group type: EXPERIMENTAL
Intervention: North Carolina Eat Smart, Move More Community Grants program (2010-2011)
Number of subjects: 2138

Group type: COMPARATOR
Intervention: North Carolina Eat Smart, Move More Community Grants program (2011-2012)
Number of subjects: 2138
Study: 24755056

Group type: EXPERIMENTAL
Intervention: Double-bundle group (DB, n=55)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Single-bundle group (SB, n=55)
Number of subjects: 110
Study: 22674240

Group type: EXPERIMENTAL
Intervention: Online occupational postural and exercise intervention
Number of subjects: 100
Study: 19507458

Group type: EXPERIMENTAL
Intervention: Intravenous zoledronic acid (ZO group)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Prescribed physical activity (PA group)
Number of subjects: 62
Study: 17418019

Group type: EXPERIMENTAL
Intervention: Preconditioning (Precond group)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Postconditioning (Postcond group)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Reinfusion (IR group)
Number of subjects: 96
Study: 16213935

Group type: EXPERIMENTAL
Intervention: Albumin-coated tympanostomy tubes
Number of subjects: 170

Group type: COMPARATOR
Intervention: Uncoated tympanostomy tubes
Number of subjects: 170
Study: 12456630

Group type: EXPERIMENTAL
Intervention: Cyclic oral estrogen/progestin (n = 25)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Long-cycle oral estrogen/quarterly progestin (n = 32)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Continuous oral estrogen/progestin (n = 21)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Continuous oral estrogen/intrauterine progestin (n = 22)
Number of subjects: 126

Group type: COMPARATOR
Intervention: No HRT (n = 26)
Number of subjects: 126
Study: 10426734

Group type: EXPERIMENTAL
Intervention: Exercise classes led by a physiotherapist including strengthening exercises, stretching exercises, relaxation session, and brief education on back care.
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Exercise classes led by a physiotherapist
Number of subjects: 187

Group type: COMPARATOR
Intervention: Usual primary care management (Control)
Number of subjects: 187
Study: 8837970

Group type: EXPERIMENTAL
Intervention: Full recovery of delusional beliefs
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Partial recovery of delusional beliefs
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: High insight
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Degree of insight during recovery
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Average degree of insight
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Insight and positive psychotic symptoms
Number of subjects: 50
Study: 1973085

Group type: EXPERIMENTAL
Intervention: CV 205-502 (0.075 mg once daily)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: CV 205-502 (0.075-0.15 mg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Bromocriptine (5 mg divided daily)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Bromocriptine (5-10 mg)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: CV 205-502
Number of subjects: 22
Study: 7213506

Group type: EXPERIMENTAL
Intervention: Once daily dosage (0.25 mg)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Twice daily dosage (0.125 mg)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Four times daily dosage (0.0625 mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: All dosage frequencies
Number of subjects: 48
Study: 31182128

Group type: EXPERIMENTAL
Intervention: Med-Stress intervention (sequential enhancement of self-efficacy and perceived social support)
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Med-Stress intervention (sequential enhancement of perceived social support and self-efficacy)
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Active control strengthening self-efficacy
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Active control strengthening perceived social support
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Med-Stress intervention
Number of subjects: 1200
Study: 28923872

Group type: EXPERIMENTAL
Intervention: Isavuconazole
Number of subjects: 231
Study: 25841539

Group type: EXPERIMENTAL
Intervention: Synbiotic yogurt (containing Streptococcus thermophilus, Lactobacillus bulgaricus, Bifidobacterium animalis subspecies lactis (BB‐12) at 5 × 10(9) cfu/100 mL and 1 g of inulin)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Synbiotic yogurt
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo (nonsynbiotic‐containing acidified milk drink)
Number of subjects: 149
Study: 23297395

Group type: EXPERIMENTAL
Intervention: 5% tea tree oil (TTO) body wash
Number of subjects: 391

Group type: COMPARATOR
Intervention: Johnson's Baby Softwash (JBS)
Number of subjects: 391
Study: 21338531

Group type: EXPERIMENTAL
Intervention: Beating the Blues program (CCBT)
Number of subjects: 510
Study: 19741531

Group type: EXPERIMENTAL
Intervention: Tricyclic antidepressants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Opioids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Selective serotonin noradrenaline reuptake inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lacosamide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Levetiracetam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phenytoin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cannabinoids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical lidocaine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topically applied capsaicin (8%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Botulinum toxin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation
Number of subjects: 0
Study: 17952153

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid, non-steroidal anti-inflammatory drugs, and COX-2 inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Faecal occult blood testing (FOBT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endoscopic screening
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sigmoidoscopy screening
Number of subjects: 0

Group type: COMPARATOR
Intervention: Colonoscopy screening
Number of subjects: 0
Study: 15184094

Group type: EXPERIMENTAL
Intervention: Sensory focus
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Affect focus
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control
Number of subjects: 82
Study: 10831773

Group type: EXPERIMENTAL
Intervention: Nimodipine
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 9478065

Group type: EXPERIMENTAL
Intervention: Fluid and salt supplementation (FSS) during hypokinesia (HK)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Unsupplemented hypokinetic subjects (UHS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (continuous exercise of 13.8 km/day)
Number of subjects: 30
Study: 1334126

Group type: EXPERIMENTAL
Intervention: Rota colostrum (20 ml per day for 2 weeks)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Rota colostrum (every other day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no Rota colostrum)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Rota colostrum (after symptoms appeared)
Number of subjects: 20
Study: 6537445

Group type: EXPERIMENTAL
Intervention: Drug education course
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 30639756

Group type: EXPERIMENTAL
Intervention: Breathlessness severity and unpleasantness measured on a 0-100 mm visual analogue scale (VAS)
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Breathlessness severity and unpleasantness assessed in the morning and evening over eight days
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Factors evaluated included age, sex, diagnosis, morning/evening assessment, modified Medical Research Council breathlessness score, morphine treatment
Number of subjects: 265
Study: 29279155

Group type: EXPERIMENTAL
Intervention: 600mgI/kg at 120‐kV tube voltage setting (600‐120 group)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 600mgI/kg at 80kV (600‐80 group)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 360mgI/kg at 80kV (360‐80 group)
Number of subjects: 120
Study: 27411273

Group type: EXPERIMENTAL
Intervention: Chimeric anterolateral thigh flap
Number of subjects: 74

Group type: COMPARATOR
Intervention: Series-wound flaps
Number of subjects: 74
Study: 14621732

Group type: EXPERIMENTAL
Intervention: CsA-AZA combination treatment
Number of subjects: 21

Group type: COMPARATOR
Intervention: CsA
Number of subjects: 21

Group type: COMPARATOR
Intervention: AZA
Number of subjects: 21
Study: 21853391

Group type: EXPERIMENTAL
Intervention: Simulator-based training (SL group)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Traditional training in the OR (OR group)
Number of subjects: 24
Study: 20511085

Group type: EXPERIMENTAL
Intervention: Forced-air gowns
Number of subjects: 150

Group type: COMPARATOR
Intervention: Warmed cotton blankets
Number of subjects: 150
Study: 18456064

Group type: EXPERIMENTAL
Intervention: Charité (Depuy) disc prosthesis
Number of subjects: 32

Group type: COMPARATOR
Intervention: Intersomatic KLA cage (Scient'x)
Number of subjects: 32
Study: 15725309

Group type: EXPERIMENTAL
Intervention: (81m)Kr SPECT
Number of subjects: 38
Study: 14622490

Group type: EXPERIMENTAL
Intervention: Redesigned midwifery-led postnatal care
Number of subjects: 2064

Group type: COMPARATOR
Intervention: Standard postnatal care
Number of subjects: 2064
Study: 11129615

Group type: EXPERIMENTAL
Intervention: Epidural PCA with bupivacaine 0.125%, sufentanil 0.75 microgram/ml and epinephrine 1/800.000 without a basal rate
Number of subjects: 80

Group type: COMPARATOR
Intervention: Epidural PCA with bupivacaine 0.125%, sufentanil 0.75 microgram/ml and epinephrine 1/800.000 with a basal rate of 3 ml/hr
Number of subjects: 80
Study: 8750479

Group type: EXPERIMENTAL
Intervention: New anticancer therapies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Psychosocial studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individual approaches by clinical investigators
Number of subjects: 0
Study: 1724541

Group type: EXPERIMENTAL
Intervention: Low-rate ANF infusion (0.25 micrograms/min)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High-rate ANF infusion (2.0 micrograms/min)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 477026

Group type: EXPERIMENTAL
Intervention: Intravenous modified immune serum globulin (M‐ISG)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intramuscular immune serum globulin (ISG)
Number of subjects: 20
Study: 31964414

Group type: EXPERIMENTAL
Intervention: Three-step feedback report design method (refinement of measures, data, and display)
Number of subjects: 13
Study: 30531397

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Midazolam (0.045 mg/kg)
Number of subjects: 6
Study: 27119222

Group type: EXPERIMENTAL
Intervention: Peer support intervention (six 1-hour sessions)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Standard of care (control group for 12 months)
Number of subjects: 98
Study: 25562479

Group type: EXPERIMENTAL
Intervention: Daily disposable contact lenses (nelfilcon A, DAILIES AquaComfort Plus)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Spectacles
Number of subjects: 110
Study: 23127169

Group type: EXPERIMENTAL
Intervention: LED group (625‐635 nm, maximum power density: 2000 mW/cm(2))
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Photosensitizer group (tolouidine blue O, 0.1 mg/ml)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: PAD group (photosensitizer and LED)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no adjunctive treatment)
Number of subjects: 16
Study: 20926751

Group type: EXPERIMENTAL
Intervention: Tonapofylline (0.2-375 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tonapofylline (in females)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tonapofylline (with food)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tonapofylline (single dose)
Number of subjects: 0
Study: 19018798

Group type: EXPERIMENTAL
Intervention: Subendocardial viability index (SVI)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: SVI calculated assuming zero LVEDP
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: DT/ST ratio
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: LVEDP
Number of subjects: 38

Group type: COMPARATOR
Intervention: Aortic pressure
Number of subjects: 38
Study: 17681360

Group type: EXPERIMENTAL
Intervention: GPO dihydroartemisinin tablet formulation, 200mg single oral dose
Number of subjects: 24

Group type: COMPARATOR
Intervention: Dafra dihydroartemisinin tablet formulation, 200mg single oral dose
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: One dose of DHA (both formulations)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Two doses of DHA (both formulations)
Number of subjects: 24
Study: 16649968

Group type: EXPERIMENTAL
Intervention: Testosterone enanthate (1 mg/kg i.m. every 4 weeks for 6 months) + Letrozole (2.5 mg/day orally for 12 months)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Testosterone enanthate (1 mg/kg i.m. every 4 weeks for 6 months) + Placebo
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Testosterone enanthate + Letrozole
Number of subjects: 17

Group type: COMPARATOR
Intervention: Testosterone enanthate + Placebo
Number of subjects: 17
Study: 12562453

Group type: EXPERIMENTAL
Intervention: Omeprazole, 20 mg/day for 5 days with 3 mg budesonide controlled-release capsules on day 5
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo for 5 days with 3 mg budesonide controlled-release capsules on day 5
Number of subjects: 13
Study: 10418761

Group type: EXPERIMENTAL
Intervention: 4 x 80 mg artemether orally
Number of subjects: 88

Group type: COMPARATOR
Intervention: 4 x 80‐480 mg co‐artemether
Number of subjects: 88
Study: 8541359

Group type: EXPERIMENTAL
Intervention: Alcohol abuse
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Marital status
Number of subjects: 0
Study: 2130823

Group type: EXPERIMENTAL
Intervention: Magnesium-rich diet (1,142.0 +/- 225 mg/day)
Number of subjects: 430

Group type: COMPARATOR
Intervention: Usual diet (438 +/- 118 mg/day)
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: Magnesium-rich diet (in hypomagnesemic patients)
Number of subjects: 430

Group type: COMPARATOR
Intervention: Usual diet (in hypomagnesemic patients)
Number of subjects: 430
Study: 374401

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Chlorpromazine
Number of subjects: 15
Study: 28648880

Group type: EXPERIMENTAL
Intervention: Animated biofeedback therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Non-animated biofeedback therapy
Number of subjects: 40
Study: 27286183

Group type: EXPERIMENTAL
Intervention: Single set of 30 s (SS)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Three sets of 30 s (MS)
Number of subjects: 66